Verified MSK & healthcare intelligence for Michigan's orthopedic leaders
Wednesday, April 22, 2026
Santosh Mudiraj, MBBS, MPH
MSK Executive Daily
Updated April 22, 2026Daily · Mon–Fri
Daily intelligence on orthopedic market trends, ASC performance, technology innovations, regulatory updates, reimbursement, and the Michigan healthcare landscape.
Reimbursement & Payment🔴 HIGH
BCBSM Pauses May 1 Modifier 25 Payment Cut for Michigan Physicians
Blue Cross Blue Shield of Michigan and Blue Care Network officially paused their planned May 1, 2026 implementation of a policy that would have reduced E&M payments by 50% for codes billed with modifier 25 alongside minor procedures with global periods of 0 or 10 days. The pause was announced April 15, 2026 following significant pressure from physician organizations including the Michigan State Medical Society and Michigan Osteopathic Association. No new implementation date has been set, and providers do not need to alter current billing practices at this time.
Why It Matters for Michigan MSK
Michigan orthopedic and MSK practices that routinely bill modifier 25 — covering same-day E&M visits during minor procedures — face significant revenue exposure if this policy ultimately takes effect. A 50% cut to these E&M services could cost an active orthopedic practice tens of thousands of dollars annually; practices should quantify their risk and stay engaged with advocacy channels as BCBSM has not permanently withdrawn the policy.
Conduct a billing audit this week to quantify your practice's exact revenue exposure from modifier 25 claims paired with minor procedures — pull the last 90 days of claims.
Engage with Michigan State Medical Society advocacy campaigns urging permanent withdrawal of this policy; document your practice's volume impact in writing to share with payer relations contacts.
Brief your billing team on current status: modifier 25 billing can continue unchanged until further notice, but prepare contingency workflows for the possibility of a revised implementation date announcement.
Reimbursement & Payment🟡 MEDIUM
Bipartisan Bill Seeks to Permanently Stabilize ASC Medicare Payments
Representatives Van Duyne (R-TX) and Larson (D-CT) introduced the Outpatient Surgery Access Act of 2026 on March 25, which would permanently align ASC Medicare payment updates with the hospital market basket rate beginning in 2027 and remove a budget-neutrality adjustment that has historically depressed ASC reimbursements. The Ambulatory Surgery Center Association (ASCA) formally endorsed the legislation. The bill argues that the CPI-U inflation tracking currently used for ASCs fails to capture healthcare-specific cost pressures — wages, equipment, malpractice — that the hospital market basket methodology is designed to reflect.
Why It Matters for Michigan MSK
Michigan orthopedic ASC operators stand to gain predictable, inflation-appropriate reimbursement increases if this bill passes, strengthening the financial case for continued MSK procedure migration to outpatient settings. Combined with the expanded ASC covered procedure list and complex joint replacement approvals, this legislation could meaningfully improve per-case margins and ASC valuation.
Contact your Congressional representatives in Michigan to express support for the Outpatient Surgery Access Act of 2026 and provide data on ASC cost efficiency in your market.
Model the financial impact of permanent hospital market basket parity on your ASC's 5-year projections and share with your board or investor partners.
Coordinate with your ASC management company or ASCA membership to track legislative progress and add collective advocacy weight through the comment and lobbying process.
Regulatory Updates🟡 MEDIUM
CMS April 2026 ASC Update Activates Expanded MSK Procedure Codes
CMS released the April 2026 Ambulatory Surgical Center Payment System update (MLN MM14445), implementing the expanded CY 2026 ASC Covered Procedures List that added 547 procedures and migrated 266 predominantly musculoskeletal codes off the Inpatient-Only list. The update introduces a new Level 7 Musculoskeletal Procedures APC classification and extends separate non-opioid pain management device payments through December 2027. ASCs meeting ASCQR quality reporting requirements receive the full 2.6% payment rate update; non-compliant facilities face a statutory 2-percentage-point reduction.
Why It Matters for Michigan MSK
Michigan orthopedic ASCs now have the billing infrastructure and Medicare reimbursement authority to perform previously inpatient-only MSK procedures in the outpatient setting. Practices that rapidly validate their chargemaster coding, confirm ASCQR compliance, and operationalize new procedure pathways will capture significant incremental case volume and revenue in 2026.
Review the full list of 266 newly added musculoskeletal procedures and identify which your surgeons can perform in your ASC setting — prioritize complex spine and joint replacement cases with the highest revenue potential.
Update your chargemaster and billing system to reflect the new Level 7 Musculoskeletal Procedures APC codes effective April 1, 2026, and verify payer contract alignment for newly added codes.
Confirm your ASCQR quality reporting compliance status to ensure you receive the full 2.6% update rather than the penalized 0.6% rate — contact your quality reporting coordinator immediately if compliance is in question.
ASC Intelligence🟡 MEDIUM
CMS Greenlights Complex Joint Replacements and Revisions in the ASC Setting
CMS finalized approval for complex joint replacement procedures — including revision total hip arthroplasty, total knee arthroplasty revisions, and partial shoulder revisions — to be performed in ASCs beginning in 2026. The policy, part of the CY 2026 OPPS/ASC final rule, removed five regulatory exclusion criteria and shifted case-level clinical judgment to the operating physician. Successful ASC implementation requires orthopedic-focused anesthesia, advanced technology, trained surgical teams, and a equitable distribution of financial benefit across the care team, according to orthopedic leaders quoted by Healio.
Why It Matters for Michigan MSK
Michigan orthopedic ASCs that establish infrastructure to safely perform complex revision joint replacements will capture higher-acuity, higher-margin cases previously reserved for hospital ORs. Early movers who credential staff, build anesthesia coverage, and develop patient selection protocols will hold a significant competitive advantage — particularly as major new Michigan orthopedic facilities (OAM, Covenant) come online in 2026–2027.
Identify which revision and complex joint replacement procedures are now billable in your ASC and which of your surgeons can be credentialed — create a list within the next 30 days.
Conduct a formal ASC readiness assessment for complex cases: confirm anesthesia support availability, 23-hour stay capability, and documented emergency transfer protocols to a partner hospital.
Model the revenue impact of adding 2–4 complex revision cases per month to your ASC schedule at current Medicare and commercial payer rates for the new procedure codes.
Michigan Healthcare Landscape🟡 MEDIUM
Grand Rapids Orthopedic Surgery Center on Track for Mid-2026 Clinical Opening
Orthopaedic Associates of Michigan (OAM), in partnership with University of Michigan Health-West and U-M Health, is progressing toward the mid-2026 opening of clinical space at its new outpatient orthopedic center in Wyoming, Michigan. The facility at 1900 Metro Court SW will feature eight operating rooms, two procedure rooms, orthopedic urgent care, occupational therapy, and 23-hour stay capability. The surgical center component is expected to open fall 2027. The joint venture structure includes UM Health-West holding a minority ownership stake, with the initiative approved by the University of Michigan Board of Regents following the sale of 8.9 acres for $5.99 million to an OAM-affiliated entity.
Why It Matters for Michigan MSK
A major new academically affiliated, eight-OR orthopedic ASC opening in the Grand Rapids market is a significant competitive development for existing West Michigan MSK providers. The OAM/UM partnership — combining independent physician group scale with academic health system credibility and a 23-hour stay capability — sets a template for practice consolidation and outpatient MSK strategy in Michigan.
Assess your Grand Rapids / West Michigan patient panel for potential migration risk to the new OAM/UM facility once clinical operations begin mid-2026 — focus on primary care referral relationships.
Review your orthopedic urgent care, OrthoNow, or same-day access strategy to maintain competitive positioning before the OAM OrthoUrgent offering becomes fully operational.
Monitor the OAM joint venture structure — particularly the minority health system ownership model — as a potential template for your own group or system partnership strategies in Michigan.
Michigan Healthcare Landscape🟡 MEDIUM
Covenant HealthCare Breaks Ground on $25M Saginaw Orthopedic Center
Covenant HealthCare broke ground April 8, 2026 on a 25,700-square-foot, $25 million orthopedic outpatient facility in Saginaw Township, Michigan, expected to open summer 2027. The facility will consolidate Covenant's outpatient orthopedic services with 44 exam rooms, four X-ray suites, casting and procedure rooms, and orthotics and prosthetics services. A key feature is Covenant OrthoExpress — described as the only orthopedic urgent care in mid-Michigan — which will provide walk-in care for acute bone, joint, and muscle injuries as an emergency room alternative. The center will be staffed by 10 orthopedic surgeons, two podiatrists, a sports medicine physician, and seven advanced practice providers.
Why It Matters for Michigan MSK
Covenant's investment establishes a comprehensive orthopedic outpatient hub in mid-Michigan, raising the bar for MSK access and convenience in the Saginaw/Bay City/Flint corridor. The OrthoExpress walk-in orthopedic urgent care model — capturing acute injuries before they reach the ER — is a patient acquisition strategy that other Michigan MSK practices should seriously evaluate for replication in their own markets.
Evaluate whether an orthopedic urgent care or "OrthoExpress"-type walk-in model makes strategic sense for your market and patient population — model volume, staffing, and payer mix assumptions.
Review your Saginaw/mid-Michigan referral relationships and outreach strategy ahead of Covenant's 2027 opening to retain referring primary care physicians and emergency departments.
Benchmark your patient access metrics (same-day/next-day availability, urgent appointment capacity) against the walk-in convenience Covenant's OrthoExpress will offer.
Technology & Innovation🟢 LOW
Osteoboost Raises $8M to Scale FDA-Cleared Wearable for Bone Loss
Osteoboost Health closed an $8 million financing round led by Ambit Health Ventures to scale manufacturing and expand commercial reach of its FDA-cleared prescription wearable for low bone density. The device delivers targeted low-magnitude vibration therapy to the lumbar spine and hips, and was proven in a double-blind clinical trial at the University of Nebraska to slow bone density loss by 85% in the spine and 55% in the hips for patients using it three times weekly. The round included participation from Emmeline Ventures, Disrupt Health Impact Fund, Esplanade Ventures, and Portfolia. Osteoboost is the first and only FDA-cleared, non-pharmacologic treatment for osteopenia in postmenopausal women.
Why It Matters for Michigan MSK
For Michigan MSK practices managing postmenopausal patients with osteopenia — a direct precursor to fragility fractures and complex orthopedic cases — Osteoboost represents an emerging prescribable, non-drug treatment option that could strengthen bone health pathways and reduce fracture incidence in your patient population. Growing investor interest signals accelerating commercialization and potential payer coverage movement ahead.
Review Osteoboost's clinical trial data and prescription pathway for potential inclusion in your bone health and fragility fracture prevention protocols for appropriate postmenopausal patients.
Connect with an Osteoboost representative to evaluate current coverage and reimbursement pathways, as this device class is at an early commercialization stage with evolving payer coverage.
Consider formalizing bone density monitoring workflows within your MSK practice to identify and proactively treat at-risk patients before fragility fractures generate complex surgical cases.
Technology & Innovation🟢 LOW
Navigation and Single-Use Power Tool Firms Partner for Cost-Efficient Joint Replacement
Intellijoint Surgical and Insurgical announced a strategic partnership on April 13, 2026 to bundle Intellijoint's open-platform navigation system for total hip and knee arthroplasty with Insurgical's single-use, factory-sterilized power tools. The partnership's commercial arrangement allows Intellijoint's US sales team to offer Insurgical's power tools alongside the navigation system, while a co-development initiative will explore integrating Intellijoint's tracking technology into Insurgical's next-generation power tool platform. The combination is designed to enable consistent, navigation-guided joint replacements without large capital equipment commitments or implant volume restrictions.
Why It Matters for Michigan MSK
Michigan orthopedic ASCs facing margin pressure from capital equipment costs and implant vendor lock-in have a new option: navigation-guided surgery with a lower cost structure, combining an open-platform nav system with sterile-ready, no-reprocessing single-use power tools. This is particularly relevant as ASCs absorb more complex joint replacement cases under the 2026 CMS approvals.
Evaluate Intellijoint's open-platform navigation system as a capital-light alternative to large robotics system investments — request a cost-per-case comparison against your current navigation or robotics arrangement.
Assess single-use power tool economics against your current power tool reprocessing costs and instrument set maintenance overhead to determine if the Insurgical model improves margins.
Schedule a demonstration of the combined Intellijoint/Insurgical workflow for your surgical leadership team and invite OR staff for workflow feedback ahead of any contracting decision.
Hospital Price Transparency Enforcement Tightens April 1
CMS UpdatesHigh Priority
CMS began enforcing new and revised Hospital Price Transparency requirements on April 1, 2026, including the requirement to replace estimated allowed amounts with median allowed amounts plus 10th and 90th percentile allowed amounts in machine-readable files. Hospitals must also encode Type 2 NPIs in the MRFs. CMS updated §180.90 to reduce Civil Monetary Penalties by 35% when a hospital waives its ALJ hearing, though hospitals violating core HPT requirements are ineligible for that reduction.
Why It Matters
Michigan MSK and orthopedic service lines billed through hospital outpatient departments must now display median and percentile allowed amounts for standard procedures. Non-compliance risk increased materially after April 1 for HOPD-based joint, spine, and sports-medicine procedures.
View Action Items
Audit MRFs for median allowed amount and 10/90 percentile fields across all MSK procedure codes.
Verify each rendering NPI (Type 2) is correctly encoded per the revised schema.
Brief revenue cycle leaders on the 35% CMP reduction pathway and waiver implications.
Effective Date: January 1, 2026Enforcement Begins: April 1, 2026
In the CY 2026 OPPS/ASC Final Rule, CMS is phasing out the Inpatient Only (IPO) list over three years, beginning with removal of 285 mostly musculoskeletal procedures in CY 2026 and adding 271 of those codes to the ASC Covered Procedures List (CPL). CMS also revised CPL criteria and added a total of 289 procedures to the ASC CPL for 2026.
Why It Matters
Michigan orthopedic groups with ASC relationships gain substantial new site-of-service options for knee, hip, and spine cases that were previously inpatient-only. Practices should reassess case selection criteria, surgeon credentialing, and payer contracting for newly ASC-eligible procedures.
View Action Items
Map the 285 newly ASC-eligible codes against current surgical case mix.
Review ASC medical staff bylaws and patient selection protocols for the new procedures.
Engage commercial payers on contract amendments for ASC site-of-service for the expanded list.
CMS finalized two separate 2026 Physician Fee Schedule conversion factors: $33.57 for qualifying APM participants (+3.77%) and $33.40 for non-qualifying clinicians (+3.26%), up from $32.35 in 2025. The update reflects a statutory +2.50% increase plus differential APM updates and work-RVU adjustments. A −2.5% efficiency adjustment applies to services deemed to have become more efficient over time, including several orthopedic codes.
Why It Matters
Michigan orthopedic practices must confirm APM participation status, since nonparticipants receive a lower conversion factor. The efficiency adjustment directly cuts RVUs on high-volume orthopedic services, requiring financial re-modeling for 2026.
View Action Items
Confirm each clinician's QP status for 2026 to apply the correct conversion factor.
Model 2026 reimbursement for top 20 orthopedic CPT codes with the efficiency adjustment.
Update fee schedule masters and payer contract benchmarks to the 2026 PFS.
The April 16, 2026 MLN Connects newsletter highlights the Ambulatory Surgical Center Payment System April 2026 update, Critical Access Hospital CRNA bypass guidance for reason codes 31006 and 31007, a new monthly adjustment process for PPS Hospital Interim Billing, and Cardiac Contractility Modulation for Heart Failure guidance. CMS also extended the ACCESS initial application deadline to May 15, 2026.
Why It Matters
Michigan MSK practices operating ASCs should apply the Q2 2026 ASC payment rates immediately and update billing rules for the new PPS hospital interim billing adjustment if affiliated with a hospital outpatient department.
View Action Items
Load the April 2026 ASC payment update into billing and charge master systems.
Review the new PPS hospital interim billing monthly adjustment process with HOPD billers.
Flag the May 15, 2026 ACCESS deadline for any participating entities.
On March 26, 2026, Governor Whitmer signed House Bill 5455 into law as PA 6 of 2026, allowing Michigan to remain a member of the Interstate Medical Licensure Compact without interruption. Prior to the legislation, physicians would not have been able to renew Michigan Expedited Medical Compact licenses after March 28, 2026.
Why It Matters
Multistate orthopedic groups with telemedicine or traveling-consultant operations can continue using IMLC-expedited licensure in Michigan. Practices should verify renewal timelines for affected physicians.
View Action Items
Audit all IMLC-expedited Michigan licenses held by employed or contracted physicians.
Communicate continued compact eligibility to physician recruiters and credentialing staff.
Monitor LARA and MSMS for implementation guidance following PA 6 of 2026.
MSMS Reimbursement Alert: McLaren Preauth Changes June 1
State Regulations MichiganMedium Priority
MSMS's April 2026 Reimbursement Advocate Alert summarizes several Michigan payer changes, including McLaren Health Plan's new upcoming preauthorization changes for Medicare effective June 1, 2026. The alert also notes that Health Alliance Plan of Michigan (HAP) requires prior authorization for all gene therapy across Commercial and Medicare Advantage lines, and CMS has clarified insulin and insulin pump coverage under Part B.
Why It Matters
McLaren Medicare preauthorization changes directly affect Michigan orthopedic practices that treat McLaren Medicare members, especially for high-cost imaging, injections, and surgical procedures. Advance preparation protects June cash flow.
View Action Items
Request McLaren's updated Medicare preauth code list and workflow before June 1.
Train front-office and auth-team staff on the HAP gene-therapy preauth requirement.
Publish an internal Michigan payer matrix summarizing the April 2026 MSMS alert items.
MDHHS loaded the January 2026 Quarterly APC & ASC software into CHAMPS on March 21, 2026 and announced in an April 1, 2026 alert that it will recycle outpatient hospital and ASC claims processed under the previous quarter's software. Providers should monitor remittance advices for reprocessed claims and balance adjustments.
Why It Matters
Michigan orthopedic ASCs and HOPD-affiliated practices will see adjustments on previously processed Q1 claims, affecting Medicaid receivables reporting and potentially producing refund requests or additional payments.
View Action Items
Reconcile April–May remittances to identify recycled APC and ASC claim adjustments.
Update financial forecasts to account for retroactive Medicaid payment changes.
Flag any negative adjustments for appeal review within MDHHS timelines.
HHS OCR's December 2024 HIPAA Security Rule Notice of Proposed Rulemaking would eliminate the distinction between "required" and "addressable" implementation specifications, require written and regularly tested policies, and better align the rule with modern cybersecurity practices. OCR cites a 102% increase in large breaches and a 1,002% increase in individuals affected from 2018–2023. Finalization is pending.
Why It Matters
Michigan orthopedic practices — which store imaging, operative plans, and implant registries — face materially higher technical and administrative safeguard expectations if the NPRM is finalized as proposed. Early gap analyses avoid rushed remediation later.
View Action Items
Commission a HIPAA Security Rule gap analysis against the NPRM requirements.
Document written policies, testing cadence, and risk-analysis updates.
Confirm business associate agreements address the expected strengthened controls.
Effective January 1, 2026, impacted payers must issue prior authorization decisions within 72 hours for urgent requests and seven calendar days for standard requests, and must provide a specific reason for denials. The 2026 MA final rule also restricts plans from reopening approved inpatient admissions absent obvious error or fraud and extends the organization-determination definition to concurrent service decisions.
Why It Matters
Michigan orthopedic groups with frequent joint replacement and spine admissions now have stronger leverage to hold MA plans to approved inpatient authorizations. Documentation of concurrent decisions drives appeal and denial strategy.
View Action Items
Track MA plan turnaround times against the 72-hour urgent and 7-day standard windows.
Escalate any MA attempts to reopen approved inpatient admissions outside error or fraud.
Preserve documentation of concurrent service decisions to support appeals.
Spring 2026 ICD-10-PCS Update Adds Spinal Device Codes
Billing & CodingMedium Priority
CMS posted the Spring 2026 ICD-10-PCS update materials, with procedure codes effective April 1, 2026 through September 30, 2026. The update includes a new device value for carbon/PEEK spinal stabilization devices applicable to cervical and thoracic fusion procedures and a new substance value for recombinant human bone morphogenetic protein-2 with collagen scaffold.
Why It Matters
Michigan spine surgeons and hospital coders must capture the new device and substance values to document implant specificity and support appropriate DRG assignment for cervical and thoracic fusions.
View Action Items
Train inpatient coders on the new carbon/PEEK and rhBMP-2 device/substance values.
Update operative note templates to document device material and substance use.
Verify chargemaster and HIM encoders reflect the April 1, 2026 PCS updates.
On March 5, 2026, OCR announced a resolution agreement with MMG Fusion, LLC over a breach affecting approximately 15 million individuals. OCR found potential violations of the HIPAA Privacy, Security, and Breach Notification Rules, including failure to conduct an accurate and thorough risk analysis and failure to notify affected covered entities. MMG agreed to a three-year corrective action plan monitored by OCR and a $10,000 payment.
Why It Matters
The settlement underscores continued OCR focus on business associate risk analyses and breach notification obligations — both relevant to Michigan orthopedic practices that share data with scheduling, RCM, and imaging vendors.
View Action Items
Verify current risk analysis is documented, current, and covers all ePHI systems.
Review BAA terms for breach notification timing and downstream obligations.
Test incident response playbooks with a tabletop exercise this quarter.
The AMA released the CPT 2026 code set with 288 new codes, 84 deletions, and 46 revisions, for 418 total changes. Updates include remote monitoring of responses to musculoskeletal and respiratory therapies, five new short-period remote monitoring codes (2–15 days within a 30-day period), and two codes that report remote monitoring treatment management at a 10-minute threshold.
Why It Matters
Michigan MSK practices running remote therapeutic monitoring programs for post-op joint and spine patients can now bill under the new shorter-period codes, improving revenue capture for condensed recovery windows.
View Action Items
Review new RTM codes against current post-operative monitoring workflows.
Update superbills and EHR code lists with the 2026 additions, deletions, and revisions.
Educate billers on the 10-minute management threshold to avoid under-coding.
AHLA's April 2026 Supplement to its Policies adds more than 60 new resources — checklists, templates, and compliance tools — covering AI scribes, False Claims Act, HIPAA enforcement, physician compensation, and labor and employment. The supplement serves as a practical reference library for compliance officers managing an expanding regulatory agenda.
Why It Matters
Michigan orthopedic practices using AI-assisted documentation tools and those renegotiating physician compensation arrangements will find ready-made templates that accelerate compliance work without reinventing controls.
View Action Items
Download the AI scribe and physician compensation templates relevant to the practice.
Map HIPAA enforcement checklists against current privacy program controls.
Assign policy ownership for each new tool adopted from the supplement.
On April 10, 2026, CMS released its FY2027 Inpatient Prospective Payment System (IPPS) Proposed Rule introducing the Comprehensive Care for Joint Replacement Expanded (CJR-X) Model—a mandatory, nationwide bundled payment program covering lower extremity joint replacements (hip, knee, and ankle). Under CJR-X, most acute care hospitals paid under IPPS would be accountable for 90-day episodes beginning with the procedure, encompassing all related Medicare Part A and Part B costs. The prior CJR model generated $112.7 million in net savings during performance years 6–7 while maintaining quality, providing the evidence base for this expansion. CJR-X would include robust risk adjustment with 29 adjusters and a 5% stop-loss for hospitals serving high dual-eligible populations.
Why It Matters for Michigan MSK
Michigan orthopedic hospitals not already participating in the TEAM model will be required to participate in CJR-X starting October 2027, fundamentally shifting financial accountability for every Medicare joint replacement episode. Programs should begin modeling their episode costs and quality benchmarks now using MARCQI and Michigan Value Collaborative data to prepare for mandatory participation.
Effective Date: October 1, 2027 (if finalized)Compliance Deadline: June 9, 2026 — Public comment period closes
Review your hospital's current TEAM model participation status and project your CJR-X episode cost exposure using MARCQI and Michigan Value Collaborative benchmarks
Submit formal comments to CMS by June 9, 2026 via the Federal Register; focus comments on risk adjustment adequacy and quality measure appropriateness for Michigan's patient population
Convene a multidisciplinary CJR-X readiness taskforce now — including orthopedic surgery, post-acute care, physical therapy, and finance — to build a 90-day episode management strategy
Under 2026 CMS orthopedic bundle requirements, a meaningful share of reimbursement is now tied to Matched Patient-Reported Outcome Measures (PROMs), requiring at least 50% of patients to complete both pre- and post-operative assessments. The THA/TKA Patient-Reported Outcome-Based Performance Measures (PRO-PMs) are mandatory for Hospital Outpatient Quality Reporting (OQR) and are increasingly weighted in CMS star ratings and Value-Based Purchasing. The American Joint Replacement Registry's 2024 annual report revealed that current one-year PROM response rates average only 25–32%, indicating most programs face a significant collection gap. AAOS published adoption resources in January 2026 to help practices close this gap.
Why It Matters for Michigan MSK
Michigan arthroplasty programs reporting through MARCQI must align their PROM collection workflows with CMS requirements or risk reimbursement adjustments and lower quality scores. The 50% matched-assessment threshold is significantly higher than current average completion rates, making digital outreach and workflow redesign an urgent operational priority.
Audit your current PROM completion rates for pre- and post-operative THA/TKA patients and measure the gap against the 50% matched-assessment threshold
Implement automated digital outreach at 7, 30, 90, and 365 days post-surgery to increase response rates; explore AI-driven tools that flag recovery plateau signals for early clinical intervention
Coordinate with your EHR or registry vendor to align MARCQI PROM data capture with CMS Hospital OQR reporting requirements and avoid duplicate documentation burden
🔴
MIPS 2026 Orthopedic Surgery MVP Registration Open Now Through November 30
MIPS🔴 High Priority
CMS has finalized the 2026 Orthopedic Surgery MIPS Value Pathway (MVP) with updated quality measures and clinical groupings, and MVP registration is now open through November 30, 2026 at 8 p.m. ET via each clinician's QPP account. Orthopedic providers reporting the Improving Care for Lower Extremity Joint Repair MVP must attest to four of seven available quality measures—at least one must be an outcome measure—plus at least one of 10 improvement activities. For 2026, CMS finalized 195 total quality measures (5 new, 32 substantively revised, 10 removed), and the performance threshold remains at 75 points, confirmed through the 2028 performance year.
Why It Matters for Michigan MSK
Michigan orthopedic practices that fail to register for the MVP pathway before November 30 will default to traditional MIPS reporting categories, potentially yielding a lower composite score and unfavorable 2028 payment adjustment. Registering early allows practices to align their quality measure selection with outcome metrics that MARCQI and BCBSM PGIP already track.
Compliance Deadline: November 30, 2026 — MVP registration closes at 8 p.m. ET
Log into your QPP account at qpp.cms.gov now and register for the 2026 Orthopedic Surgery MVP; do not wait until November — early registration allows time to configure reporting workflows
Review the updated Lower Extremity Joint Repair MVP measure set and select the outcome measure your practice can most reliably track (e.g., functional status, complication rate, or patient-reported outcome)
Confirm that your practice's Promoting Interoperability (PI) infrastructure meets the 2026 foundational layer requirements, as PI is mandatory for all MVP reporters regardless of specialty
🔴
BCBSM 2026 Hospital Pay-for-Performance CQI Index Now Active; April Snapshot Underway
Michigan Quality Initiatives🔴 High Priority
Blue Cross Blue Shield of Michigan has released its 2026 Hospital Pay-for-Performance Program guidelines and the updated Collaborative Quality Initiatives (CQI) Performance Index. Each CQI is scored on a 100-point basis, and hospitals participating in multiple CQIs have their scores combined into a single overall performance figure that directly affects pay-for-performance incentive payments. BCBSM conducts two annual data snapshots—in April and October—and the April snapshot window is now active, making accurate and timely registry data submission critical. Over 75 Michigan hospitals actively participate in CQIs, with 87% of large and mid-size acute care hospitals enrolled in at least one collaborative.
Why It Matters for Michigan MSK
Michigan orthopedic programs participating in MARCQI and MSSIC have their CQI performance scores directly factored into BCBSM pay-for-performance incentives. The active April snapshot means any data gaps, abstraction errors, or missing case submissions for hip and knee arthroplasty procedures will affect 2026 performance scores and reimbursement.
Effective Date: 2026 performance year (active now)Compliance Deadline: April snapshot window — submit data promptly
Verify that your hospital's 2026 hip and knee arthroplasty case data is being accurately abstracted and submitted to the MARCQI registry before the April snapshot window closes
Download and review the 2026 BCBSM CQI Performance Index Guide (available at bcbsm.com) to understand your scoring methodology, point weighting, and areas where your program can earn additional credit
Engage your data abstraction team to reconcile any flagged discrepancies or missing data fields in the MARCQI and MSSIC dashboards before the snapshot is taken
🟡
MHA Keystone Center Launches Quality and Safety Dashboard for Michigan Hospitals
Michigan Quality Initiatives🟡 Medium Priority
The Michigan Health & Hospital Association (MHA) Keystone Center has rolled out its new Quality and Safety Dashboard—a web-based tool accessible through the KeyMetrics platform—giving Michigan hospitals real-time visibility into patient safety and quality performance metrics. The dashboard integrates hospital administrative claims, CDC National Healthcare Safety Network (NHSN) infection surveillance data, maternal health indicators, and AHRQ Patient Safety Indicators (PSIs) focused on potentially preventable in-hospital complications. The April 20, 2026 MHA Monday Report confirmed the dashboard is live and available to member hospitals, with MHA Keystone staff offering account setup and navigation support.
Why It Matters for Michigan MSK
Michigan orthopedic programs can now benchmark their surgical complication rates, infection metrics, and readmission performance against statewide peers through a single standardized dashboard—a powerful complement to MARCQI registry data for identifying gaps before BCBSM CQI performance snapshots are taken.
Contact the MHA Keystone Center to set up or verify your hospital's KeyMetrics account and access the Quality and Safety Dashboard; request onboarding support if your team is new to the platform
Run an initial dashboard report filtered for surgical complications, post-operative infection rates, and joint replacement readmissions, and compare against Michigan statewide benchmarks
Integrate dashboard findings into your quarterly quality committee reporting to create a unified view of performance across the MHA, MARCQI, and BCBSM CQI data sources
🟡
MSQC Activates 2026 Quality Portfolio Including Frailty and SUCCESS Projects
Michigan Quality Initiatives🟡 Medium Priority
The Michigan Surgical Quality Collaborative (MSQC) has launched its 2026 quality improvement portfolio, anchored by the SUCCESS Project, Frailty Project, Breast Surgical Quality Measures Project, Colorectal Cancer (CRC) Project, and Abdominal Hernia Surgeon Engagement Project. The Frailty Project targets one of the most modifiable pre-operative risk factors for post-surgical complications and readmissions. MSQC is hosting a SCQR Training Day on July 17, 2026 in Detroit and the 2026 Surgical Summit on September 18, 2026. The collaborative unites Michigan hospitals in data sharing and best-practice dissemination to improve surgical quality statewide.
Why It Matters for Michigan MSK
The MSQC Frailty Project has direct relevance for Michigan arthroplasty programs: frail patients have markedly higher rates of post-operative complications, readmissions, and discharge to skilled nursing facilities after joint replacement—outcomes that now drive HRRP penalties and BCBSM CQI performance scores. Standardized frailty screening protocols from MSQC can be adapted for orthopedic pre-operative workups.
Key Event: MSQC SCQR Training Day — July 17, 2026, DetroitKey Event: MSQC Surgical Summit — September 18, 2026
Review the 2026 MSQC quality initiatives at msqc.org/quality-improvement/2026-msqc-quality-initiatives and identify which projects align with your orthopedic program's quality improvement priorities
Register your surgical quality team for the MSQC SCQR Training Day on July 17, 2026 to ensure accurate data abstraction for BCBSM CQI performance scoring
Adapt MSQC's Frailty Project screening protocol for use in your arthroplasty pre-operative evaluation workflow to identify and optimize at-risk patients before elective joint replacement
🟡
Joint Commission's 14 National Performance Goals Replace Patient Safety Goals in 2026
Patient Safety🟡 Medium Priority
Effective January 1, 2026, The Joint Commission replaced the longstanding National Patient Safety Goals (NPSGs) chapter with a new National Performance Goals (NPGs) framework consisting of 14 high-priority, measurable topics organized to support continuous, year-round improvement rather than point-in-time compliance. The NPGs address patient identification, staffing safety, infection prevention, medication management, fall prevention, care equity, and other domains. Hospitals must demonstrate compliance with NPGs to surveyors to maintain accreditation. The chapter reorganization also changes how requirements are numbered and cross-referenced in hospital policies.
Why It Matters for Michigan MSK
Michigan orthopedic and MSK programs that have not yet updated their accreditation-ready documentation, staff training, and compliance protocols to reflect the NPG chapter structure and new goal numbering risk survey-readiness gaps. Programs should complete the NPSG-to-NPG transition audit before their next Joint Commission survey window.
Effective Date: January 1, 2026
Download the 2026 Hospital National Performance Goals document from jointcommission.org and conduct a gap analysis against your current NPSG-based compliance policies and procedures
Update all staff training and orientation materials to reference the new NPG chapter structure, revised goal numbers, and year-round performance tracking expectations
Schedule an internal mock survey using the NPG framework and updated scoring methodology before your hospital's next scheduled accreditation survey date
🟡
AAOS Revises Guideline on Antibiotic Prophylaxis and Dental Timing for THA/TKA Patients
Infection Prevention🟡 Medium Priority
The American Academy of Orthopaedic Surgeons issued an updated Clinical Practice Guideline (CPG) for prevention of periprosthetic joint infection (PJI) in total hip and knee arthroplasty (THA/TKA) patients undergoing dental procedures, replacing the 2012 version. Key recommendations: routine systemic antibiotic prophylaxis before dental procedures may not reduce PJI risk; non-invasive dental care can be performed until the day before TJA; oral surgery and extractions should be completed at least 3 weeks before TJA; and most dental procedures should be delayed until at least 3 months post-TJA. AAOS hosted a February 2026 webinar to bridge orthopedics and dentistry on the updated guidance.
Why It Matters for Michigan MSK
Michigan orthopedic surgeons should update pre-operative patient counseling protocols and care coordination with dental partners to align with the new evidence-based recommendations, which may reduce unnecessary antibiotic prescriptions while clarifying true PJI timing risks for patients and referring dentists.
Update your practice's pre-operative TJA patient education materials and consent documentation with the revised dental procedure timing recommendations from the AAOS CPG
Distribute the updated guideline summary to dental colleagues and oral surgeons in your referral network who treat joint replacement patients, noting the 3-week pre-TJA and 3-month post-TJA timing thresholds
Review your current antibiotic prophylaxis protocol for dental procedures in post-TJA patients and align with the guideline's limited-strength evidence against routine prophylaxis, consulting with infectious disease as needed
🟡
CMS HRRP FY2026: ~2,400 Hospitals Face Readmission Penalties; THA/TKA Included
Readmissions🟡 Medium Priority
Under the Hospital Readmissions Reduction Program (HRRP) for FY2026 (October 1, 2025–September 30, 2026), approximately 2,400 hospitals face Medicare payment penalties for excess readmissions, with about 8% facing reductions of 1% or more up to the statutory cap of 3%. Total hip and knee arthroplasty (THA/TKA) have been tracked under HRRP since FY2015–2016 and remain included in the current performance year. The FY2026 performance period uses claims data from July 1, 2021 through June 30, 2024. Penalties are applied to every qualifying Medicare inpatient payment through September 30, 2026.
Why It Matters for Michigan MSK
Michigan hospitals performing joint replacement surgery should verify their FY2026 HRRP penalty status now on QualityNet; excess THA/TKA readmission penalties compound with MIPS performance gaps and CJR-X episode cost overruns, creating layered financial risk for orthopedic programs that have not addressed readmission reduction systematically.
Effective Date: FY2026 penalties active October 1, 2025–September 30, 2026Performance Period: July 1, 2021–June 30, 2024
Pull your hospital's FY2026 HRRP penalty status from QualityNet and calculate the annualized payment reduction impact on your orthopedic service line revenue
Analyze your top diagnosis groups driving 30-day THA/TKA readmissions (infection, VTE, cardiac events, falls) and prioritize modifiable risk factors for immediate intervention
Implement structured discharge follow-up protocols—including 48-hour post-discharge calls, physical therapy milestone checks, and wound surveillance—to reduce preventable readmissions before the FY2027 performance period begins (July 1, 2024–June 30, 2025)
🟢
MSSIC Drives Statewide Spine Quality with $50M–$70M in Estimated Cumulative Savings
MSSIC🟢 Low Priority
The Michigan Spine Surgery Improvement Collaborative (MSSIC), a BCBSM Value Partnerships program launched in 2013, continues its 2026 quality improvement work connecting orthopedic surgeons, neurosurgeons, hospitals, and ambulatory surgical facilities across Michigan. The collaborative focuses on reducing surgical complications, urinary retention, surgical site infections, emergency department utilization, and readmissions, while improving patient-reported outcomes and ensuring patients ambulate within 8 hours of surgery. Cumulative estimates suggest $50–$70 million in savings for BCBSM and other payers to date, not including indirect cost savings from faster return to work and reduced caregiver burden.
Why It Matters for Michigan MSK
Michigan spine surgery programs should actively use MSSIC's toolkit and registry data to benchmark against statewide peers, particularly as the CMS TEAM model now includes spinal fusion in its mandatory episode accountability framework—making MSSIC's quality work directly relevant to both CQI performance scores and federal payment program compliance.
Review MSSIC's current quality improvement toolkit and focus areas at mssic.org and align your spine program's quality priorities with the collaborative's 2026 initiatives to maximize CQI performance credit
Ensure your spine surgery program is capturing and submitting PROMs to MSSIC at required intervals, as PROM completion rates are a weighted component of BCBSM pay-for-performance scores
Identify opportunities to reduce post-spine-surgery ED utilization and unplanned readmissions using MSSIC's collaborative benchmark data and apply successful interventions from top-performing Michigan sites
AI & Healthcare Analytics
Updated April 16, 2026
Twice-weekly intelligence on healthcare AI adoption, digital health, analytics, AI regulation, startups, big tech, and automation impacting MSK and orthopedic operations.
🔴AI RegulationHIGH
CMS Adds Reimbursement Code for AI-Detected Coronary Calcium on Routine Chest CT
CMS established HCPCS code G0680 in April 2026, creating a formal reimbursement pathway for AI-powered algorithmic analysis of coronary artery calcium (CAC) and aortic valve calcification detected opportunistically on chest CT scans. An estimated 19 million general chest CTs are performed annually in the U.S., yet 20–40% of incidental coronary calcium goes unreported; AI tools can now flag this automatically. STAT News reported that while coverage is a significant step, questions remain about implementation workflows and whether systematic reporting will translate to improved downstream outcomes.
Why It Matters for MSK & Orthopedic Leaders
Orthopedic practices routinely encounter patients with chest imaging ordered by other specialists. This CMS code signals a broader shift toward opportunistic AI-powered screening embedded in routine imaging workflows — a model that could rapidly extend to musculoskeletal findings on non-MSK scans, creating new documentation and billing obligations for Michigan practices.
→ Review your current radiology reporting protocols to determine if AI-detected incidental findings (including MSK-related) are systematically captured and documented for billing under emerging codes.
→ Engage your radiology and IT partners to assess readiness for AI opportunistic screening tools that align with CMS G0680 reimbursement criteria and could be extended to orthopedic imaging contexts.
→ Monitor CMS guidance updates through Q2 2026 for additional opportunistic screening codes that may affect orthopedic imaging workflows and revenue cycle operations.
Luminai Raises $38M, Deploys AI Operations Platform at Cleveland Clinic
AI healthcare operations company Luminai closed a $38 million Series B on April 9, 2026 — bringing total funding to $60 million — led by Peak XV Partners with participation from Define Ventures, General Catalyst, and Y Combinator. Simultaneously, the company announced an enterprise deployment with Cleveland Clinic, which serves 15 million patients across 23 hospitals, beginning with AI-powered automated routing of faxed referrals across thousands of potential destinations. The platform has already enabled more than 12 million automations, with an average time-to-value of 48 days.
Why It Matters for MSK & Orthopedic Leaders
Referral routing is one of the highest-friction points in Michigan orthopedic access — fax-based systems remain endemic. Luminai's Cleveland Clinic deployment is a bellwether for how large Midwest health systems will automate referral intake; orthopedic practices dependent on inbound referrals from major systems should anticipate and prepare for AI-driven routing logic that may change referral patterns and response time expectations.
→ Audit your referral intake infrastructure to identify fax-dependent bottlenecks that are likely targets for AI automation by referring health systems over the next 12–18 months.
→ Engage your care coordination and operations team to evaluate AI-assisted referral management platforms — including Luminai and peers — to ensure your practice can interface with automated referral systems from large health networks.
→ Track Cleveland Clinic's AI deployment outcomes as a regional case study that may inform adoption decisions at Michigan-based health systems including Henry Ford and Beaumont/Corewell.
UnitedHealth's $3 Billion AI Push: Efficiency Gains vs. Patient Safety Scrutiny
UnitedHealth Group is directing approximately $3 billion toward AI initiatives as part of its 2026 strategy, with $1.6 billion planned for this year alone. More than 80% of its 22,000 engineers already use AI tools, and the company is deploying AI to automate claims processing, select billing codes, and cut prescription reauthorizations by 25%. The AI chatbot Avery is being scaled from 6.5 million to 20.5 million members by year-end, while the company simultaneously faces federal investigations and a class-action lawsuit alleging its nH Predict AI algorithm denied Medicare Advantage post-acute care claims with a reported 90% error rate.
Why It Matters for MSK & Orthopedic Leaders
UnitedHealth is Michigan's largest commercial insurer by membership. Its aggressive AI-driven prior authorization and claims processing expansion will directly affect orthopedic and MSK practices through faster automated denials, shifting documentation expectations, and new appeal pathways — while the litigation over nH Predict creates political and regulatory pressure that may reshape payer AI guardrails in 2026.
→ Review your practice's UnitedHealth prior authorization denial rate trends from Q1 2026 to identify patterns that may reflect AI-driven claim adjudication changes and adjust clinical documentation standards proactively.
→ Brief your revenue cycle and compliance team on the nH Predict litigation and emerging federal investigations so they can escalate anomalous denials through appropriate legal and regulatory channels.
→ Engage your state or national orthopedic society to participate in comment processes if CMS or Congress opens rulemaking on payer AI decision-making transparency requirements in 2026.
Hospitals Launch Patient-Facing AI Chatbots to Reclaim Health Conversations
Hartford HealthCare and K Health launched PatientGPT in April 2026, a 24/7 AI assistant embedded directly in the Hartford HealthCare patient portal that allows patients to access plain-language lab results, identify potential medication interactions, schedule appointments, and escalate to live clinicians through on-demand virtual care. STAT News reported that health systems are deploying patient-facing chatbots as a competitive strategy to prevent patients from turning to general-purpose consumer AI tools like ChatGPT for clinical questions. PatientGPT does not diagnose or prescribe and is limited to patients 18 and older in Connecticut, with patient data ring-fenced from external AI training.
Why It Matters for MSK & Orthopedic Leaders
Patient-facing AI is rapidly becoming a patient experience differentiator for health systems; orthopedic and MSK practices that rely on health system referral relationships should assess whether patient portal AI tools could streamline pre-visit education, post-op FAQs, and rehab compliance — reducing inbound call volume while improving outcomes data capture.
→ Evaluate whether your current patient portal (Epic MyChart, Athena, etc.) has AI chatbot capabilities that are inactive or underutilized that could be configured to handle common orthopedic patient inquiries.
→ Survey your patient population on use of consumer AI tools (ChatGPT, Gemini) for health questions to understand how patients are already seeking information outside your clinical relationship.
→ Pilot a patient-facing FAQ chatbot for your top 10 most-asked pre-op and post-op questions to measure call deflection and patient satisfaction impact before committing to enterprise vendor solutions.
AI Scribes Are Raising Healthcare Costs, Stakeholders Agree — Solutions Remain Elusive
A roundtable convened by the Peterson Health Technology Institute confirmed in April 2026 that investors, health plans, and providers share a consensus that AI ambient scribes are driving up healthcare costs by increasing coding intensity — resulting in more billable diagnoses and higher-acuity visit codes per encounter. Research from health data firm Trilliant Health corroborates that doctor visits have grown more expensive following AI scribe adoption. Despite industry-wide agreement on the problem, no consensus solution has emerged, with payers, providers, and technology vendors pointing fingers at each other over accountability and audit mechanisms.
Why It Matters for MSK & Orthopedic Leaders
Michigan orthopedic practices adopting AI ambient scribes (Abridge, Nuance DAX, Suki, etc.) should proactively audit coding output for unexpected uplifts in E&M levels or diagnosis coding density, which may trigger commercial payer audits or recoupment requests — especially as UnitedHealth and BCBSM expand AI-driven claims scrutiny in parallel.
→ Run a 90-day retrospective analysis comparing E&M code distribution and average claim value before and after AI scribe implementation at your practice to identify statistically significant uplifts.
→ Establish a clinical documentation integrity (CDI) review protocol for AI-generated notes with a qualified coder to ensure documentation supports — but does not inflate — coded complexity.
→ Request your AI scribe vendor's published data on coding accuracy and false-positive diagnosis capture rates, and confirm their audit indemnification policies before expanding deployment.
Innovaccer Pledges $250M Over Three Years to Scale Agentic AI Clinical Platform
Innovaccer announced a $250 million, three-year commitment to expand its agentic AI platform for healthcare, which automates workflows across prior authorization, revenue cycle management, risk stratification, and population health. The investment targets enterprise health systems including Kaiser Permanente, Ascension, and Trinity Health — linking contact center agents to population health workflows in an integrated "agentic cloud." The strategic rationale is that CFOs are moving from point-solution AI to enterprise-wide AI architectures that address structural labor shortages and sweeping operational problems simultaneously.
Why It Matters for MSK & Orthopedic Leaders
Agentic AI platforms that automate prior authorization and risk stratification at health system scale will alter the speed and logic of MSK care approvals; orthopedic practices partnered with Innovaccer-enabled systems should anticipate AI-generated utilization management signals and prepare for faster — but algorithmically mediated — authorization decisions for high-cost MSK interventions.
→ Determine whether any of your major Michigan payer or health system partners are Innovaccer customers and request a briefing on how their AI agents interact with orthopedic prior auth workflows.
→ Assess your practice's prior authorization denial and turnaround data against industry benchmarks to establish a baseline before agentic AI systems from payers reshape authorization timelines.
→ Explore whether your practice management or EHR vendor offers agentic AI workflow tools — for scheduling, prior auth submission, or risk identification — to remain operationally competitive with health system-scale deployments.
American Specialty Health Adds Injury Prevention Module to Digital MSK Platform
American Specialty Health (ASH) expanded its Digital MSK Platform on April 15, 2026, with a third self-care module focused on injury prevention — delivering individualized movement exercises, strength-building routines, and body-awareness techniques designed by licensed physical therapists. The platform, which already covers 100+ million eligible members and offers acute injury recovery and chronic pain management modules, is positioned at 50–70% cost savings compared to competing digital MSK offerings. Members may use the injury prevention module independently or escalate to ASH's national virtual PT/OT network for clinical support.
Why It Matters for MSK & Orthopedic Leaders
ASH's scale — 100+ million eligible members — means this injury prevention module will intercept a significant portion of the musculoskeletal patient funnel that would otherwise convert to orthopedic referrals. Michigan practice leaders should understand how payer-sponsored digital MSK programs are being deployed in their patient population and model the downstream volume impact on elective orthopedic procedures.
→ Identify which of your major commercial payer contracts include American Specialty Health or comparable digital MSK benefit programs, and analyze whether those payers are steering members away from in-person PT or orthopedic consultations.
→ Evaluate whether partnering with or integrating digital MSK prevention tools into your care continuum could strengthen payer value-based contracts and reduce avoidable acute-care utilization.
→ Track outcomes data published by ASH and comparable platforms (Hinge Health, Kaia Health) to build evidence-based positioning for in-person MSK care when digital-first approaches are insufficient.
Analysis: AI Cannot Fix Broken Clinical Workflows in MSK Care Platforms
A new analysis published April 15, 2026 by HIT Consultant argues that AI layered onto structurally deficient MSK care platforms does not resolve the "clinical resolution gap" — the failure to actually change patient outcomes — because MSK is among the largest cost drivers in employer-sponsored plans (approximately 17 cents of every healthcare dollar) yet digital MSK solutions have frequently over-promised clinical outcomes. The piece contends that AI-driven engagement and prediction tools require fundamentally sound clinical protocols beneath them before they can deliver measurable resolution, and that many current MSK AI deployments optimize engagement metrics rather than functional improvement or cost deflection.
Why It Matters for MSK & Orthopedic Leaders
As payers and employers expand digital MSK investments, Michigan orthopedic practices are positioned to offer the clinical depth that AI-only solutions cannot replace — particularly for high-complexity patients who fail conservative digital care. This analysis provides useful evidence for value-based conversation with employers and payers about when in-person orthopedic expertise is clinically essential.
→ Collect outcomes data (functional improvement, surgery avoidance, return-to-work rates) from your practice to build a counter-narrative to digital MSK platforms when competing for value-based payer contracts.
→ Explore step-therapy partnership models with digital MSK vendors where your practice receives referrals for patients who fail AI-guided conservative care protocols — turning digital MSK into a referral feeder rather than a competitor.
→ Share this analysis with your clinical leadership team to inform your strategic positioning ahead of employer and payer contract negotiations in H2 2026.